UK markets closed

HOOKIPA Pharma Inc. (HOOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8910-0.0392 (-4.21%)
As of 02:04PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 92.04M
Enterprise value -18.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.37
Price/book (mrq)1.02
Enterprise value/revenue -0.92
Enterprise value/EBITDA 0.24

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-40.77%
S&P500 52-week change 322.38%
52-week high 32.0500
52-week low 30.4100
50-day moving average 30.7680
200-day moving average 30.6717

Share statistics

Avg vol (3-month) 3801.24k
Avg vol (10-day) 32.11M
Shares outstanding 596.55M
Implied shares outstanding 698.95M
Float 858.31M
% held by insiders 119.59%
% held by institutions 139.38%
Shares short (15 Apr 2024) 4316.71k
Short ratio (15 Apr 2024) 40.59
Short % of float (15 Apr 2024) 40.33%
Short % of shares outstanding (15 Apr 2024) 40.32%
Shares short (prior month 15 Mar 2024) 4333.39k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-244.76%

Management effectiveness

Return on assets (ttm)-32.00%
Return on equity (ttm)-84.81%

Income statement

Revenue (ttm)20.13M
Revenue per share (ttm)0.21
Quarterly revenue growth (yoy)-5.40%
Gross profit (ttm)N/A
EBITDA -81.38M
Net income avi to common (ttm)-81.58M
Diluted EPS (ttm)-0.8600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)117.1M
Total cash per share (mrq)1.18
Total debt (mrq)6.56M
Total debt/equity (mrq)7.30%
Current ratio (mrq)3.50
Book value per share (mrq)0.91

Cash flow statement

Operating cash flow (ttm)-57.52M
Levered free cash flow (ttm)-39.97M